Kohno et al. reported that auraptene significantly reduced the rates of cyclooxygenase (COX)-2, proliferating cell nuclear antigen (PCNA), nitrotyrosine and inducible nitric oxide (iNOS) in adenocarcinomas. Here, PCNA is linked to adenocarcinoma.